Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples